ANNUAL REPORT 2008 KNOWLEDGE TO TRANSFORMATION Sir Peter MacCallum (1885 –1974 ) believed nothing but the best was good enough when it came to cancer treatment. His vision helped build the Peter MacCallum Cancer Centre – Australia’s most comprehensive and internationally acclaimed centre for cancer treatment and research. “As much as I hated being CONTENTS Who We Are 04 in hospital, the people Highlights 06 Technology 10 at Peter Mac were fantastic Report from the Chair and Chief Executive Officer 12 – they always had a smile and 2007 – 08 Overall Performance 16 Patient Care 22 encouraged me all the way.” Clinical Services Breast Kim Lane Gastrointestinal Melbourne University student, 2008 Gynae-oncology Haematology Head and Neck Kim Lane was a Year 12 student when she was diagnosed with leukaemia in 2006. Lung While undergoing treatment at Peter Mac, Kim courageously kept up her studies Melanoma and Skin and sat her final exams, passing with flying colours. Neuro-oncology Paediatrics, Adolescents, Young Adult and Late Effects Sarcoma Uro-oncology Familial Cancer Centre Allied Health Occupational Therapy Nutrition Social Work Music Therapy Physiotherapy Clinical Psychology Pain and Palliative Care Satellite Units 40 Research 44 Education, Training and Professional Development 46 Community Spirit 50 Our People 58 Organisational Structure 70 Corporate Governance and Report of Operations 72 Financial Statements 87 Kim Lane (centre) with friends Anita Dass and Kelly Messiter. WHO WE ARE VISION MULTIDISCIPLINARY MODEL PATIENT CARE Peter Mac will be recognised by the OF CARE community and professional peers, nationally CLINICAL TRIALS and internationally, as a premier resource for Peter Mac is a global leader in cancer therapy, Peter Mac is a leader in the delivery of cancer cancer patients in the provision of integrated research, education and training. The Centre care in a true multidisciplinary fashion and treatment, research and education. has an enviable reputation in delivering the 11 Clinical Services provide a means multidisciplinary patient care and aims to set to further develop this model of cancer care. MIssION national standards in therapy and treatment As Australia’s foremost specialist cancer – increasingly within an integrated model Clinical trials described in this report outline centre, Peter Mac provides quality treatment of supportive care for many types of cancer. sophisticated evaluation of new compounds and support to patients and their families. that we believe will have a significant impact Underpinned by research and the best We are based in East Melbourne, with on patient survival. Peter Mac has a special evidence available, Peter Mac broadly satellite units at Bendigo Radiotherapy role in the Australian landscape to advance influences cancer care in the community Centre, Epworth Eastern Medical Centre at new treatment and evaluate the findings through multidisciplinary partnerships, Box Hill, Moorabbin and Tasttersall’s Cancer of others, to speed their appropriate and research and education. Centre – Epworth Richmond. (see page 40) timely adoption in Australia. (see page 22) VALUES We deliver world-class cancer care to patients MODEL OF SUPPORTIVE CARE We strive for Excellence, ensuring that nationally and internationally, seeing around Peter Mac’s Supportive Care services work clinical practice is evidence based, patient 8,400 new patients each year. In 2007 – 08 hand-in-hand with its world-leading cancer centred and is provided by qualified and we provided 21,913 admitted inpatient treatment services, to create the best holistic experienced staff who are accountable and episodes and 206,492 outpatient occasions cancer service to patients. Supportive care appropriately credentialled. of service. provides services to people living with or affected by cancer to meet their physical, We strive to ensure that Innovation social, emotional, informational, psychological, is fostered by supporting research and spiritual and practical needs during the a learning culture. pre-diagnostic, diagnostic, treatment and follow-up phases of cancer. Adhering to the strongest ethical standards to ensure a culture of openness, mutual respect Our model of supportive care can be applied and trust, Compassion is at our core. in principle to each of these need domains and ensures the timely delivery of services in accordance with the needs of each patient. Peter MacCallum Cancer Centre Annual Report 2008 RESEARCH – KNOWLEDGE COMMITMENT TO LEARNING PETER MAC IN THE COMMUNITY TO TRANSFORMATION Peter Mac’s commitment to learning attracts Peter Mac is a household name in the In a globalised world it is important to play the best possible recruits who wish to pursue community. Our base may be in East to one’s strengths, and at Peter Mac cancer a career in the field of cancer through Melbourne, but our unique blend research is one of its shining stars. Peter Mac classroom teaching at universities and of treatment and support is available has strengths in performing large-scale postgraduate placements in its advanced at satellite units at Bendigo, Box Hill, studies with specific patient cohorts, such medical science program. Moorabbin and the Epworth (Richmond) as women with ovarian cancer or those who (see page 40), and extends into patients’ have a family history of breast cancer. We also Peter Mac’s reputation as a renowned homes through the successful have a strong focus on use of advanced teaching centre educates medical staff from Peter Mac@Home program, which technologies to enable research that was other institutions. Students come from all over offers professional nursing care to its previously not feasible. the world to learn new treatment protocols patients in their own homes. that have been developed or undertaken for Peter Mac’s laboratory and clinical research the first time in Australia by Peter Mac. Its effort in cancer is the largest in Australia, important findings are regularly published with over 450 dedicated scientists, clinician- in prestigious medical journals, and its experts researchers, research nurses, support staff invited to present their works at international and allied health professionals, integrating scientific meetings. (see page 46) basic, translational and clinical research with patient care in the setting of a specialist cancer hospital – knowledge to transformation. (see page 44) (www.petermac-research.org.au) WHO WEWE ARE ARE 05 5 HIGHLIGHTS 2007 – 08 Peter Mac is a national identity, committed to excellence in cancer research and patient care. Launch of the Victorian State-of-the-art Centre for Functional integrated digital Genomics (VCFG), the operating theatre, first of its kind in Australia the most advanced (see page 10) laparoscopic equipment available for surgery Translational Oncology (see page 10) Research Collaborative Hub (TORCH) will help First Australian hospital achieve groundbreaking to implement MedNet, results in the fight against a wireless intravenous cancer (see page 10) error reduction software system (see page 10) Actively minimising greenhouse emissions, Melanoma patient Clare our Information Oliver – the powerful Technology Department legacy of one person has reduced the number influencing legislative of servers at Peter Mac change to control the from 52 to just 16 use of sunbeds (see page 56) More rigorous monitoring systems and savings Our Apheresis unit is the strategies for energy only one of its kind in and water use have Australia (see page 11) been put in place under the Going Green @ A total of $13,320,376 Peter Mac banner in generous donations received from our community (see page 50) Peter MacCallum Cancer Centre Annual Report 2008 KNOWLEDGE CLINICAL FINDINGS INFORMING RESEARCH INFORMING CLINICAL FINDINGS transformation IN treatment TRANSFORMATION HIGHLIGHTS 07 Peter Mac in collaboration with Pfizer Inc established the Translational Oncology Research Collaborative Hub (TORCH), with the aim of achieving groundbreaking research results in the fight against cancer. Assoc Professor Danny Rischin, Professor Rod Hicks and Assoc Professor Grant McArthur worked with Pfizer Inc to establish TORCH at Peter Mac. TECHnologY Takes US to NEW HEIGHTS PETER MAC AND PFIZER JOIN VICTORIAN CENTRE FOR NeW DiGITAL OPERATING THEATRE FORCES FOR THE FUTURE FUNCTIONAL GENOMICS OF CANCER RESEARCH In January 2008, a fully integrated digital The Victorian Centre for Functional Genomics operating theatre was installed at Peter Mac Peter Mac in collaboration with Pfizer Inc (VCFG) was launched at Peter Mac in May, – the most advanced laparoscopic equipment established the Translational Oncology 2008, by The Hon Gavin Jennings MLC, available for surgery today. Research Collaborative Hub (TORCH), Minister for Innovation. which was launched in May, 2008. The new operating theatre makes it possible The centre will provide Victorian researchers to increase the number and range of Pharmaceutical company Pfizer Inc has with the opportunity to access a key procedures conducted by doctors, with less committed AUS$15 million funding to technology platform, which is the first of its invasive techniques. By using cameras and support medical research and cancer drug kind in Australia. Through the development keyhole surgery, patients experience less development over the next three years. of this platform, our ability to assess the post-operative pain and recover more quickly. The collaboration will integrate three key function of each gene in the human genome This new approach will expand therapeutic